Yozo Shimizu
Tokai University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yozo Shimizu.
Annals of the New York Academy of Sciences | 1981
Shigeru Arimori; Kenji Koriyama; Yozo Shimizu; Kazuko Hiramatsu
Myasthenia gravis (MG) is a disease caused by the impairment of neuromuscular junctions and characterized by high incidence of thymic involvement including thymoma or thymic hyperp1asia.l It has been demonstrated that the antibody against acetylcholine receptors (AChR) is present in sera of MG patienh2 The AChR has been found not only in synaptic membranes but also in thymic epithelial cells and thymic lymphocyte^.^ The antibody against AChR (anti-AChR antibody) is responsible for abnormality of neuromuscular j ~ n c t i o n . ~ Although direct evidence that peripheral lymphocytes of MG patients bear AChR is not found at present, abnormal findings such as decreased mitogenic activities,G higher response to AChR,7 and decreased T-cell in MG lymphocytes, and B-cell clone in the thymus were revealed. This evidence indicated that cell-mediated immune responses represented by lymphocytes play significant roles in the pathogenesis of MG. It is, therefore, of great interest to study the surface structures and functions of myasthenic lymphocytes resulting from the interaction between their receptors and anti-receptor antibodies since the impaired postsynaptic membrane is caused by the analogous interaction between AChR and the anti-AChR antibodies. The morphological alteration of cell surface can be observed by radioautography, ferritin or enzyme conjugated immunoelectron microscopy, immunoscanning electron microscopy and freeze-fractured technique. The functional changes in cell membranes can be evaluated by measuring the receptor activities and membrane microviscosity.8 We studied the relation between ultrastructural alterations and microviscosity of the cell membrane in the peripheral blood lymphocytes from MG patients, from the viewpoint that the alteration of MG lymphocyte membranes may represent the impairment of postsynaptic membranes in MG.
The Tokai journal of experimental and clinical medicine | 1981
Yukinobu Ichikawa; Masatoshi Takaya; Kunihiko Yamauchi; Yozo Shimizu; Kenji Koriyama; Shigeru Arimori
The Tokai journal of experimental and clinical medicine | 1980
Shigeru Arimori; Tadami Nagao; Yozo Shimizu; Katsuto Watanabe; Mitsumoto Komatsuda
The Tokai journal of experimental and clinical medicine | 1978
Yukinobu Ichikawa; Masatoshi Takaya; Kunihiko Yamauchi; Yozo Shimizu; Shigeru Arimori
The Tokai journal of experimental and clinical medicine | 1980
Yozo Shimizu
The Tokai journal of experimental and clinical medicine | 1980
Shigeru Arimori; Kenji Koriyama; Kazuko Hiramatsu; Yozo Shimizu; Yoshiaki Matsumura
Japanese Journal of Thrombosis and Hemostasis | 1980
Shigeru Arimori; Yozo Shimizu; Masayuki Endo; Kazuko Hiramatsu; Hiroyuki Nozaki
The Tokai journal of experimental and clinical medicine | 1979
Yasuo Nomoto; Hideto Sakai; Yozo Shimizu; Shigeru Arimori; Mikio Kato; Hiroshi Saito; Takeshi Sato; Toru Arima; Nozomu Imai
Japanese Journal of Thrombosis and Hemostasis | 1979
Shigeru Arimori; Kazuyo Sumitomo; Yozo Shimizu; Tadami Nagao; Yukinobu Ichikawa
The Tokai journal of experimental and clinical medicine | 1978
Yozo Shimizu; Masatoshi Takaya; Yasuo Nomoto; Hideto Sakai; Shigeru Arimori